Stockhead joined with IR Department and Morgans for HealthInvest 2024 in Sydney last week
The event highlighted some of ASX’s leading and up-and-coming biotech and life sciences companies
Imricor Medical Systems, Race Oncology, Clarity Pharmaceuticals, Percheron Therapeutics and ImpediMed all presented
Special Report: The biotech/life sciences sector is in good shape in 2024 and looks primed to enter a period of strong growth. At…
Read More…